-
boyan bonev, biochemistry, biophysics, membrane, drug-target recognition, antibiotic, toxin, nmr, nuclear magnetic resonance, electron microscopy, nisin
cell wall inhibition 
www.boyancho.com - 2009-02-04
-
The entry page to ADV BioSicence Web site
doxcycline gene knockin lentivector lentiviral infection lentiviral packaging tet-off tet-on
www.advbioscience.com - 2009-02-10
-
Prosarix Ltd provides computational drug discovery to partner companies and generates preclinical development compounds for out-licensing utilising its ...
5HT1A de novo design homology modelling in silico drug discovery ligand based drug design protein target
www.prosarix.com - 2009-02-10
-
Sygnis is a biotechnology company which pioneers innovative therapies for neurological disorders. Sygnis offers partnering opportunities for the ...
www.basf-lynx.com - 2009-02-05
-
DGI leads in applying the zebrafish model organism to determine gene functions and identify drug targets. Our proprietary technology assesses vertebrate gene ...
David Largaespada Discovery Genomics drug target validation in vivo gene function morphant morphant technology Perry Hackett Scott McIvor sleeping beauty transposon Stephen Ekker transposase
www.discoverygenomics.net - 2009-02-14
-
Cellzome - a leader in the world of chemical proteomics and drug discovery
cellzome chemical proteomics drug pull down pathway expansion TAP-MS
www.cellzome.com - 2009-02-15
-
AngioGenetics is a start-up drug discovery company focusing on angiogenesis - the formation of new blood vessels.
www.angiogenetics.se - 2009-02-04
-
AngioGenetics is a start-up drug discovery company focusing on angiogenesis - the formation of new blood vessels.
www.leadartis.com - 2009-02-06
-
Cambridge Biotechnology Ltd (CBT) is a privately owned, UK based, neuroscience drug discovery company with a core interest in the treatment of pain and clinical ...
drug-discovery
www.camb-biotech.com - 2009-02-05
|
|
|
